Individual needs vary by body weight, protein goals, activity level, and food tolerance
Cardiovascular data on endpoints like MACE-3 or MACE-4 are presently not available yet, but an early meta-analysis demonstrated at least cardiovascular safety in patients with T2D treated with tirzepatide (78, 79)
As a matter of fact, in 2019, an oral GLP-1 receptor agonist called semaglutide was approved for type 2 diabetes treatment in the United States and Europe
Injection technique, including proper needle placement and consistent site rotation, matters more for reliable dosing than choosing one site over another
According to the company, people will be able to get single-dose vials with a prescription from a Ro-affiliated healthcare professional
10.3748/wjg.v30.i48.5205 77 SoliniA.TricD.Del PratoS